Reaction

Adult T-Cell Lymphoma/Leukaemia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 458 reports · 5 co-occurring drugs

As of the last recalculation, Adult T-Cell Lymphoma/Leukaemia appears in 458 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is BRENTUXIMAB VEDOTIN (PRR 112.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Brentuximab Vedotin	24	112.2	112.5
Lenalidomide	189	33.9	33.9
Doxorubicin Hydrochloride	17	24.5	24.5
Micafungin Sodium	4	21.6	21.6
Etoposide	31	20.5	20.5

Related reactions

Drug Ineffective
Off Label Use
Death
Nausea
Fatigue

Data source: openFDA FAERS. See the OpenPV methodology and limitations.